: Guidance - Concall Update For Q1 FY27, UPL guides for 10% to 14% revenue growth and 14% to 18% EBITDA growth, noting Q1 is typically a slower quarter with lower EBITDA margins due to seasonality. Q1 FY27 revenue growth is expected to be driven by volume growth in India SAS, Advanta, and SUPERFORM, with UPL Corp. being largely flat, alongside positive price impact and a 7% to 9% positive FX impact. For FY27, CapEx is projected to be between $300 million to $350 million, an increase from FY26's $261 million, to enhance margins and build additional EBITDA, particularly in specialty chemicals and backward integration. The company aims for a comfortable working capital cycle time of around 65 days, compared to the 53 to 57 days achieved in the last two years, and a medium-term net debt to EBITDA ratio of 1.2 to 1.5 times. The effective tax rate for FY27 is guided to be around 20% to 22%, with the NPP segment targeting a CAGR of approximately 12% between FY26 and FY31, and $700 million in revenue for FY27, aiming for $1 billion by FY31.